he Chinese government has published guidelines intended to accelerate the reform of drug and medical device regulation in the country.
China’s General Office of the State Council issued the document and seeks to enhance the legal and regulatory frameworks for drug and medical device supervision improve the quality and efficiency of the review and approval processes for innovative drugs and devices by 2027....[China MNPA]
